The 2023 International Conference on Innovative Research in Nucleic Acid and Protein Chemical Structural Biology Drugs was successfully concluded in Suzhou on April 21-22, 2023! The conference covers nucleic acid drugs, gene information storage, nucleic acid replication and transcription, protein translation, nucleic acid gene sequence determination, regulation of nucleic acid gene information, nucleic acid gene expression, signal transduction and biological growth and development, etc. Chinese Peptide company was invited to participate in this exhibition, and there was a strong academic exchange atmosphere, during which Chinese Peptide company exhibitors had a lively discussion with all the guests and colleagues in the industry.
Founded in 2001, Chinese peptide company is a trusted global integrated peptide/nucleic acid CRDMO partner. The production base of the Chinese peptide company and the new base in the United States will simultaneously ensure the product delivery of global customers, and provide global customers with a long-term stable supply chain of peptide apis, so as to better respond to the growing customer demand.
The peptide nucleic acid business is led by national and provincial experts. Nucleic acid project covers an area of 15 acres, construction area of about 26,700 square meters, after the completion of the project will form a 10-story ground building and three-story podium of modern drug research and development and production base. Through complementary and collaborative cooperation with Chinese peptide company, the Group will eventually build a global polypeptide/nucleic acid integrated whole industry chain platform, determined to help partners more compliant, safe and efficient development of patients in urgent need of drugs, and will also provide more comprehensive services for more pharmaceutical companies around the world.